Summary

GlobalData's new report, "Germany In Vitro Diagnostics Market Outlook to 2016" provides key market data on the Germany In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories-clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

-Market size and company share data for In Vitro Diagnostics (IVD) market categories-clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
-Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
-2009 company shares and distribution shares data for each of the seven market categories.
-Global corporate-level profiles of key companies operating within the Germany In Vitro Diagnostics (IVD) market.
-Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

-Develop business strategies by identifying the key market categories and segments poised for strong growth.
-Develop market-entry and market expansion strategies.
-Design competition strategies by identifying who-stands-where in the Germany In Vitro Diagnostics (IVD) competitive landscape.
-Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
-What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

Table of Contents

 

1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 What is This Report About? 16
3 In Vitro Diagnostics In Germany 17
3.1 In Vitro Diagnostics, Market Segmentation 17
3.2 In Vitro Diagnostics, Germany, Overall Revenue ($m), 2002-2016 18
3.3 In Vitro Diagnostics Market, Germany, Revenue Mix ($m), 2009 20
3.4 In Vitro Diagnostics Market, Germany, Category Contribution (%), 2009 21
3.5 In Vitro Diagnostics, Germany, Company Share (2008-2009) 27
4 Clinical Chemistry In Germany 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, Germany, Revenue Mix ($m), 2009 29
4.3 Clinical Chemistry Market, Germany, Category Contribution (%), 2009 30
4.4 Clinical Chemistry Overall Revenue (2002-2016) 31
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 35
4.4.2 Urine Analysis Revenue (2002-2016) 39
4.5 Clinical Chemistry Distribution Share (2008-2009) 43
4.6 Clinical Chemistry, Germany, Company Share (2008-2009) 44
5 Genetic Testing In Germany 46
5.1 Genetic Testing, Market Segmentation 46
5.2 Genetic Testing Market, Germany, Revenue Mix ($m), 2009 47
5.3 Genetic Testing Market, Germany, Category Contribution (%), 2009 48
5.4 Genetic Testing Overall Revenue (2002-2016) 49
5.5 Genetic Testing Distribution Share (2008-2009) 53
5.6 Genetic Testing, Germany, Company Share (2008-2009) 54
6 Haematology In Germany 55
6.1 Haematology, Market Segmentation 55
6.2 Haematology Market, Germany, Revenue Mix ($m), 2009 56
6.3 Haematology Market, Germany, Category Contribution (%), 2009 57
6.4 Haematology Overall Revenue (2002-2016) 58
6.4.1 Haematology Reagents Revenue (2002-2016) 62
6.4.2 Immunohaematology Revenue (2002-2016) 66
6.4.3 Haemostasis Revenue (2002-2016) 70
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 74
6.4.5 Haematology Cell Counters Revenue (2002-2016) 78
6.5 Haematology Distribution Share (2008-2009) 82
6.6 Haematology, Germany, Company Share (2008-2009) 83
7 Histology And Cytology In Germany 85
7.1 Histology and Cytology, Market Segmentation 85
7.2 Histology and Cytology Market, Germany, Revenue Mix ($m), 2009 86
7.3 Histology And Cytology Market, Germany, Category Contribution (%), 2009 87
7.4 Histology And Cytology Overall Revenue (2002-2016) 88
7.4.1 Histology Revenue (2002-2016) 92
7.5 Histology and Cytology Distribution Share (2008-2009) 96
7.6 Histology and Cytology, Germany, Company Share (2008-2009) 97
8 Immuno Chemistry In Germany 99
8.1 Immuno Chemistry, Market Segmentation 99
8.2 Immuno Chemistry Market, Germany, Revenue Mix ($m), 2009 100
8.3 Immuno Chemistry Market, Germany, Category Contribution (%), 2009 101
8.4 Immuno Chemistry Overall Revenue (2002-2016) 102
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 106
8.4.2 Drug Related Testing Revenue (2002-2016) 110
8.4.3 Endocrinology Tests Revenue (2002-2016) 114
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 118
8.5 Immuno Chemistry Distribution Share (2008-2009) 122
8.6 Immuno Chemistry, Germany, Company Share (2008-2009) 123
9 Infectious Immunology In Germany 125
9.1 Infectious Immunology, Market Segmentation 125
9.2 Infectious Immunology Market, Germany, Revenue Mix ($m), 2009 126
9.3 Infectious Immunology Market, Germany, Category Contribution (%), 2009 127
9.4 Infectious Immunology Overall Revenue (2002-2016) 128
9.5 Infectious Immunology Distribution Share (2008-2009) 132
9.6 Infectious Immunology, Germany, Company Share (2008-2009) 133
10 Microbiology Culture In Germany 135
10.1 Microbiology Culture, Market Segmentation 135
10.2 Microbiology Culture Market, Germany, Revenue Mix ($m), 2009 136
10.3 Microbiology Culture Market, Germany, Category Contribution (%), 2009 137
10.4 Microbiology Culture Overall Revenue (2002-2016) 138
10.4.1 Microbiology Analyzers Revenue (2002-2016) 142
10.5 Microbiology Culture Distribution Share (2008-2009) 146
10.6 Microbiology Culture, Germany, Company Share (2008-2009) 147
11 Overview of Key Companies in Germany In Vitro Diagnostics Market 149
11.1 F. Hoffmann-La Roche Ltd. 149
11.1.1 Company Overview 149
11.2 Share in the Germany In Vitro Diagnostics Market 149
11.3 Siemens Healthcare 150
11.3.1 Company Overview 150
11.4 Share in the Germany In Vitro Diagnostics Market 150
11.5 Beckman Coulter, Inc. 151
11.5.1 Company Overview 151
11.6 Share in the Germany In Vitro Diagnostics Market 151
11.7 Abbott Laboratories 152
11.7.1 Company Overview 152
11.8 Share in the Germany In Vitro Diagnostics Market 152
11.9 bioMerieux S.A. 153
11.9.1 Company Overview 153
11.10 Share in the Germany In Vitro Diagnostics Market 153
11.11 Sysmex Corporation 154
11.11.1 Company Overview 154
11.12 Share in the Germany In Vitro Diagnostics Market 154
11.13 Inverness Medical Innovations, Inc. 155
11.13.1 Company Overview 155
11.14 Becton, Dickinson and Company 155
11.14.1 Company Overview 155
11.15 Bio-Rad Laboratories, Inc. 156
11.15.1 Company Overview 156
11.16 Hologic, Inc. 156
11.16.1 Company Overview 156
11.17 OLYMPUS CORPORATION 157
11.17.1 Company Overview 157
11.18 Mindray Medical International Limited 157
11.18.1 Company Overview 157
11.19 Ortho-Clinical Diagnostics Inc. 158
11.19.1 Company Overview 158
11.20 DiaSorin S.p.A 158
11.20.1 Company Overview 158
11.21 Qiagen N.V. 158
11.21.1 Company Overview 158
11.22 Bayer HealthCare AG 159
11.22.1 Company Overview 159
11.23 Gen-Probe Incorporated 159
11.23.1 Company Overview 159
11.24 Phadia AB 160
11.24.1 Company Overview 160
11.25 AMODIA Bioservice GmbH 160
11.25.1 Company Overview 160
11.26 SIRS-Lab GmbH 160
11.26.1 Company Overview 160
11.27 ACGT ProGenomics AG 160
11.27.1 Company Overview 160
11.28 BAG Health Care GmbH 161
11.28.1 Company Overview 161
11.29 Scil Diagnostics GmbH 161
11.29.1 Company Overview 161
11.30 BioRepair GmbH 161
11.30.1 Company Overview 161
11.31 Biotest AG 162
11.31.1 Company Overview 162
11.32 Scienion AG 162
11.32.1 Company Overview 162
11.33 Invitek Biotechnolgy & Biodesign Ltd. 162
11.33.1 Company Overview 162
11.34 ScheBo Biotech AG 163
11.34.1 Company Overview 163
11.35 Serion Immundiagnostica GmbH 163
11.35.1 Company Overview 163
11.36 Viramed Biotech AG 163
11.36.1 Company Overview 163
11.37 5 PRIME GmbH 164
11.37.1 Company Overview 164
11.38 MEDIPAN GmbH 164
11.38.1 Company Overview 164
11.39 BioCat GmbH 164
11.39.1 Company Overview 164
11.40 8sens.biognostic GmbH 164
11.40.1 Company Overview 164
11.41 Hain Lifescience GmbH 165
11.41.1 Company Overview 165
11.42 mtm laboratories AG 165
11.42.1 Company Overview 165
11.43 STRATEC Biomedical Systems AG 165
11.43.1 Company Overview 165
12 In Vitro Diagnostics Market Pipeline Products 166
12.1 Clinical Chemisty Market Pipeline Products 166
12.2 Immuno Chemistry Market Pipeline Products 168
12.3 Haematology Market Pipeline Products 170
12.4 Infectious Immunology Market Pipeline Products 171
12.5 Microbiology Culture Market Pipeline Products 173
12.6 Histology and Cytology Market Pipeline Products 174
12.7 Genetic Testing Market Pipeline Products 175
13 Financial Deals Landscape 177
13.1 Acquisition 177
13.1.1 QIAGEN Completes Acquisition Of ESE 177
13.1.2 Bio-Rad Laboratories Completes Acquisition Of Medical Diagnostics Segment From Biotest 178
13.1.3 Sonic Healthcare Acquires 100% Of Lademannbogen Laboratory 180
13.2 Partnerships 181
13.2.1 QIAGEN Enters Into Distribution Agreement With Celera 181
13.2.2 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 182
13.2.3 Technogenetics Signs Distribution Agreement With A. Menarini Diagnostics 183
13.2.4 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 184
14 Recent Developments 185
14.1 Government and Public Interest 185
14.1.1 Feb 01, 2010: New Testing Method To Detect Cancer In Initial Stages 185
14.2 Product News 186
14.2.1 Dec 08, 2009: QuantRx Introduces Q-Reader At MEDICA 2009 186
14.2.2 Nov 10, 2009: Svenson And HairDX Introduce Genetic Hair Loss Test In Germany 186
14.2.3 Jun 09, 2009: Roche¡äs NimbleGen Sequence Capture Arrays And xCELLigence Cell Analysis System Stands Among Ten Top Innovative Products Of 2008 In China 187
15 Appendix 188
15.1 Definitions of Markets Covered in the Report 189
15.1.1 In Vitro Diagnostics 189
15.2 Research Methodology 193
15.3 Secondary Research 193
15.4 Primary Research 193
15.5 Models 193
15.6 Forecasts 193
15.7 Expert Panels 193
15.8 GlobalData Consulting 193
15.9 Currency Conversion 193
15.10 Contact Us 193
15.11 Disclaimer 193

 

1.1 List of Tables
Table 1: In Vitro Diagnostics, Germany, Overall Revenue ($m), 2002-2016 19
Table 2: In Vitro Diagnostics Market, Germany, Category Contribution (%), 2009 21
Table 3: In Vitro Diagnostics, Germany, Cross-Category Analysis, 2002-2016 22
Table 4: In Vitro Diagnostics, Germany, Overall Revenue ($m), Historic, 2002-2009 24
Table 5: In Vitro Diagnostics, Germany, Overall Revenue ($m), Forecast, 2009-2016 26
Table 6: In Vitro Diagnostics, Germany, Company Share by Revenue ($m), 2008-2009 27
Table 7: Clinical Chemistry Market, Germany, Category Contribution (%), 2009 30
Table 8: Clinical Chemistry, Germany, Revenue ($m) by Segment, Historic, 2002-2009 32
Table 9: Clinical Chemistry, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 34
Table 10: Clinical Chemisty Analyzers, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 36
Table 11: Clinical Chemisty Analyzers, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 38
Table 12: Urine Analysis, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Table 13: Urine Analysis, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 42
Table 14: Clinical Chemistry, Germany, Distribution Share by Revenue ($m), 2008-2009 43
Table 15: Clinical Chemistry, Germany, Company Share by Revenue ($m), 2008-2009 45
Table 16: Genetic Testing Market, Germany, Category Contribution (%), 2009 48
Table 17: Genetic Testing, Germany, Revenue ($m) by Segment, Historic, 2002-2009 50
Table 18: Genetic Testing, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 52
Table 19: Genetic Testing, Germany, Distribution Share by Revenue ($m), 2008-2009 53
Table 20: Genetic Testing, Germany, Company Share by Revenue ($m), 2008-2009 54
Table 21: Haematology Market, Germany, Category Contribution (%), 2009 57
Table 22: Haematology, Germany, Revenue ($m) by Segment, Historic, 2002-2009 59
Table 23: Haematology, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 61
Table 24: Haematology Reagents, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 63
Table 25: Haematology Reagents, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 65
Table 26: Immunohaematology, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 67
Table 27: Immunohaematology, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 69
Table 28: Haemostasis, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71
Table 29: Haemostasis, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73
Table 30: Haematology Rapid Tests, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 75
Table 31: Haematology Rapid Tests, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 77
Table 32: Haematology Cell Counters, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 79
Table 33: Haematology Cell Counters, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81
Table 34: Haematology, Germany, Distribution Share by Revenue ($m), 2008-2009 82
Table 35: Haematology, Germany, Company Share by Revenue ($m), 2008-2009 84
Table 36: Histology And Cytology Market, Germany, Category Contribution (%), 2009 87
Table 37: Histology And Cytology, Germany, Revenue ($m) by Segment, Historic, 2002-2009 89
Table 38: Histology And Cytology, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 91
Table 39: Histology, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 93
Table 40: Histology, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 95
Table 41: Histology And Cytology, Germany, Distribution Share by Revenue ($m), 2008-2009 96
Table 42: Histology And Cytology, Germany, Company Share by Revenue ($m), 2008-2009 98
Table 43: Immuno Chemistry Market, Germany, Category Contribution (%), 2009 101
Table 44: Immuno Chemistry, Germany, Revenue ($m) by Segment, Historic, 2002-2009 103
Table 45: Immuno Chemistry, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 105
Table 46: Disease Specific Immunochemistry, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 107
Table 47: Disease Specific Immunochemistry, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 109
Table 48: Drug Related Testing, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 111
Table 49: Drug Related Testing, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 113
Table 50: Endocrinology Tests, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 115
Table 51: Endocrinology Tests, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 117
Table 52: Immunochemistry Analyzers, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 119
Table 53: Immunochemistry Analyzers, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 121
Table 54: Immuno Chemistry, Germany, Distribution Share by Revenue ($m), 2008-2009 122
Table 55: Immuno Chemistry, Germany, Company Share by Revenue ($m), 2008-2009 124
Table 56: Infectious Immunology Market, Germany, Category Contribution (%), 2009 127
Table 57: Infectious Immunology, Germany, Revenue ($m) by Segment, Historic, 2002-2009 129
Table 58: Infectious Immunology, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 131
Table 59: Infectious Immunology, Germany, Distribution Share by Revenue ($m), 2008-2009 132
Table 60: Infectious Immunology, Germany, Company Share by Revenue ($m), 2008-2009 134
Table 61: Microbiology Culture Market, Germany, Category Contribution (%), 2009 137
Table 62: Microbiology Culture, Germany, Revenue ($m) by Segment, Historic, 2002-2009 139
Table 63: Microbiology Culture, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 141
Table 64: Microbiology Analyzers, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 143
Table 65: Microbiology Analyzers, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 145
Table 66: Microbiology Culture, Germany, Distribution Share by Revenue ($m), 2008-2009 146
Table 67: Microbiology Culture, Germany, Company Share by Revenue ($m), 2008-2009 148
Table 68: Clinical Chemisty Market Pipeline Products 166
Table 69: Immuno Chemistry Market Pipeline Products 168
Table 70: Haematology Market Pipeline Products 170
Table 71: Infectious Immunology Market Pipeline Products 171
Table 72: Microbiology Culture Market Pipeline Products 173
Table 73: Histology and Cytology Market Pipeline Products 174
Table 74: Genetic Testing Market Pipeline Products 175
Table 75: QIAGEN Completes Acquisition Of ESE 177
Table 76: Bio-Rad Laboratories Completes Acquisition Of Medical Diagnostics Segment From Biotest 178
Table 77: Sonic Healthcare Acquires 100% Of Lademannbogen Laboratory 180
Table 78: QIAGEN Enters Into Distribution Agreement With Celera 181
Table 79: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 182
Table 80: Technogenetics Signs Distribution Agreement With A. Menarini Diagnostics 183
Table 81: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 184
Table 82: USD to Local Currency, Germany, Average Actual Rate 2002-2009 193

 

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 17
Figure 2: In Vitro Diagnostics, Germany, Overall Revenue ($m), 2002-2016 18
Figure 3: In Vitro Diagnostics Market, Germany, Revenue Mix ($m), 2009 20
Figure 4: In Vitro Diagnostics Market, Germany, Category Contribution (%), 2009 21
Figure 5: In Vitro Diagnostics, Germany, Cross-Category Analysis, 2002-2016 22
Figure 6: In Vitro Diagnostics, Germany, Overall Revenue ($m), Historic, 2002-2009 23
Figure 7: In Vitro Diagnostics, Germany, Overall Revenue ($m), Forecast, 2009-2016 25
Figure 8: In Vitro Diagnostics, Germany, Company Share (%), 2009 27
Figure 9: Clinical Chemistry, Market Segmentation 28
Figure 10: Clinical Chemistry Market, Germany, Revenue Mix ($m), 2009 29
Figure 11: Clinical Chemistry Market, Germany, Category Contribution (%), 2009 30
Figure 12: Clinical Chemistry, Germany, Revenue ($m) by Segment, Historic, 2002-2009 31
Figure 13: Clinical Chemistry, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 33
Figure 14: Clinical Chemisty Analyzers, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35
Figure 15: Clinical Chemisty Analyzers, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37
Figure 16: Urine Analysis, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Figure 17: Urine Analysis, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Figure 18: Clinical Chemistry, Germany, Company Share (%), 2009 44
Figure 19: Genetic Testing, Market Segmentation 46
Figure 20: Genetic Testing Market, Germany, Revenue Mix ($m), 2009 47
Figure 21: Genetic Testing Market, Germany, Category Contribution (%), 2009 48
Figure 22: Genetic Testing, Germany, Revenue ($m) by Segment, Historic, 2002-2009 49
Figure 23: Genetic Testing, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 51
Figure 24: Genetic Testing, Germany, Company Share (%), 2009 54
Figure 25: Haematology, Market Segmentation 55
Figure 26: Haematology Market, Germany, Revenue Mix ($m), 2009 56
Figure 27: Haematology Market, Germany, Category Contribution (%), 2009 57
Figure 28: Haematology, Germany, Revenue ($m) by Segment, Historic, 2002-2009 58
Figure 29: Haematology, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 60
Figure 30: Haematology Reagents, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Figure 31: Haematology Reagents, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64
Figure 32: Immunohaematology, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66
Figure 33: Immunohaematology, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 68
Figure 34: Haemostasis, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 70
Figure 35: Haemostasis, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72
Figure 36: Haematology Rapid Tests, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74
Figure 37: Haematology Rapid Tests, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 76
Figure 38: Haematology Cell Counters, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 78
Figure 39: Haematology Cell Counters, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 80
Figure 40: Haematology, Germany, Company Share (%), 2009 83
Figure 41: Histology And Cytology, Market Segmentation 85
Figure 42: Histology And Cytology Market, Germany, Revenue Mix ($m), 2009 86
Figure 43: Histology And Cytology Market, Germany, Category Contribution (%), 2009 87
Figure 44: Histology And Cytology, Germany, Revenue ($m) by Segment, Historic, 2002-2009 88
Figure 45: Histology And Cytology, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 90
Figure 46: Histology, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 92
Figure 47: Histology, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 94
Figure 48: Histology And Cytology, Germany, Company Share (%), 2009 97
Figure 49: Immuno Chemistry, Market Segmentation 99
Figure 50: Immuno Chemistry Market, Germany, Revenue Mix ($m), 2009 100
Figure 51: Immuno Chemistry Market, Germany, Category Contribution (%), 2009 101
Figure 52: Immuno Chemistry, Germany, Revenue ($m) by Segment, Historic, 2002-2009 102
Figure 53: Immuno Chemistry, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 104
Figure 54: Disease Specific Immunochemistry, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 106
Figure 55: Disease Specific Immunochemistry, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108
Figure 56: Drug Related Testing, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 110
Figure 57: Drug Related Testing, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 112
Figure 58: Endocrinology Tests, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 114
Figure 59: Endocrinology Tests, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 116
Figure 60: Immunochemistry Analyzers, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 118
Figure 61: Immunochemistry Analyzers, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 120
Figure 62: Immuno Chemistry, Germany, Company Share (%), 2009 123
Figure 63: Infectious Immunology, Market Segmentation 125
Figure 64: Infectious Immunology Market, Germany, Revenue Mix ($m), 2009 126
Figure 65: Infectious Immunology Market, Germany, Category Contribution (%), 2009 127
Figure 66: Infectious Immunology, Germany, Revenue ($m) by Segment, Historic, 2002-2009 128
Figure 67: Infectious Immunology, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 130
Figure 68: Infectious Immunology, Germany, Company Share (%), 2009 133
Figure 69: Microbiology Culture, Market Segmentation 135
Figure 70: Microbiology Culture Market, Germany, Revenue Mix ($m), 2009 136
Figure 71: Microbiology Culture Market, Germany, Category Contribution (%), 2009 137
Figure 72: Microbiology Culture, Germany, Revenue ($m) by Segment, Historic, 2002-2009 138
Figure 73: Microbiology Culture, Germany, Revenue ($m) by Segment, Forecast, 2009-2016 140
Figure 74: Microbiology Analyzers, Germany, Revenue ($m) by Sub-Segment, Historic, 2002-2009 142
Figure 75: Microbiology Analyzers, Germany, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 144
Figure 76: Microbiology Culture, Germany, Company Share (%), 2009 147
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),Germany In Vitro Diagnostics Market, 2009 149
Figure 78: Siemens Healthcare, Company Share (%),Germany In Vitro Diagnostics Market, 2009 150
Figure 79: Beckman Coulter, Inc., Company Share (%),Germany In Vitro Diagnostics Market, 2009 151
Figure 80: Abbott Laboratories, Company Share (%),Germany In Vitro Diagnostics Market, 2009 152
Figure 81: bioMerieux S.A., Company Share (%),Germany In Vitro Diagnostics Market, 2009 153
Figure 82: Sysmex Corporation, Company Share (%),Germany In Vitro Diagnostics Market, 2009 154
Figure 83: GlobalData Methodology 193